A Xarelto lawsuit has alleged that Xarelto is fraudulently represented.

In his Xarelto lawsuit, plaintiff Jermaine M. alleges that the makers of Xarelto negligently left out or downplayed serious potential health problems their drug could cause.

Xarelto is a blood thinner or anticoagulant, a class of drugs designed to be used to decrease the risk of stroke, some types of heart attack, and other medical problems wherein an errant blood clot lodges in the blood vessels that feed critical internal organs. Blood thinners are given to patients at risk for this type of medical problem in order to decrease their risk of suffering these life-threatening events.

But all blood thinners carry the risk of working too well. Without the ability to form blood clots, a person can bleed to death from a very minor injury. Sometimes, blood thinners like Xarelto make it too hard for patients to form blood clots. Older blood thinners like Warfarin have an available reversal agent. This means that if a patient on Warfarin suffers from uncontrollable bleeding, doctors can give them the reversal agent, allowing them to form blood clots and stop bleeding. However, newer-generation blood thinners like Xarelto do not have known reversal agents, although drug companies are racing to get a working reversal agent through human trials. In the meantime, patients with Xarelto bleeding are difficult for doctors to treat. At present, doctors must rely on massive transfusions to try and keep patients alive.

According to this Xarelto lawsuit, the makers of Xarelto did not adequately test the drug, and mostly relied on information about other blood thinners when advertising and promoting Xarelto. His Xarelto lawsuit says that Jermaine M. suffered a life-threatening Xarelto bleeding incident from the drug. His Xarelto lawsuit holds that the makers of Xarelto exposed him to the risk of uncontrollable bleeding when they marketed a drug that Jermaine holds was not adequately tested and did not have an available reversal agent. His Xarelto bleed lawsuit claims that it was fraudulent to promote Xarelto based on available data, when safer alternatives like older blood thinners existed, and holds that Xarelto’s makers hid their knowledge of these defects from the public, the FDA, and the medical community.

This Xarelto lawsuit seeks to recoup the cost of emergency medical care, allegedly required due to uncontrollable bleeding caused by Xarelto. The Xarelto lawsuit also seeks to recoup compensation for ongoing medical costs, pain and suffering, lost wages/lost income potential, and other costs allowable under law.

The Xarelto lawsuit is Case No. 0019, in the U.S. District Court for the Northern District of West Virginia.